Company Overview

Update
Headquarters:
San Francisco, CA
Funding:
$22M
Categories:
Biotechnology
Description:
Trellis Bioscience is a therapeutic antibody company developing treatments for infectious diseases and oncology indications.

Detailed Description

Update

Trellis Bioscience develops a technology platform for cellular informatics. The company’s technology has applications in the discovery and production of therapeutic monoclonal antibodies. Its cell biology platform provides a direct readout at the single cell level for monitoring activity of diverse cell types and quantifying the impact of potential therapeutic interventions. The company is based in San Francisco, California.

Current Team (1)

Update

Past Team (1)

Update

Funding Rounds (3) - $22M

Update

Investments (1)

Update

Board Members and Advisors (1)

Update

Investors (4)

Update

Offices/Locations (1)

Update
  • HQ

    2-B Corporate Drive

    San Francisco, CA 94080

    USA

Images (1)

Update
  • B1237f2ea0b27ed806d319197c5e6db2